Welcome to LookChem.com Sign In|Join Free

CAS

  • or

68236-35-1

Post Buying Request

68236-35-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

68236-35-1 Usage

General Description

2-BROMO-6-CHLOROTHIENO[2,3-B]PYRIDINE is a chemical compound with the molecular formula C7H4BrClNS. It is a heterocyclic compound that contains a pyridine ring fused to a thieno ring with bromine and chlorine substituents. 2-BROMO-6-CHLOROTHIENO[2,3-B]PYRIDINE is commonly used as a building block in the synthesis of pharmaceuticals and agrochemicals. It has been studied for its potential use as a pesticide and as an antifungal agent. 2-BROMO-6-CHLOROTHIENO[2,3-B]PYRIDINE is also used in the research and development of new chemical compounds due to its unique structure and reactivity.

Check Digit Verification of cas no

The CAS Registry Mumber 68236-35-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,8,2,3 and 6 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 68236-35:
(7*6)+(6*8)+(5*2)+(4*3)+(3*6)+(2*3)+(1*5)=141
141 % 10 = 1
So 68236-35-1 is a valid CAS Registry Number.
InChI:InChI=1/C7H3BrClNS/c8-5-3-4-1-2-6(9)10-7(4)11-5/h1-3H

68236-35-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Bromo-6-chlorothieno[2,3-b]pyridine

1.2 Other means of identification

Product number -
Other names 2-bromo-6-chlorothieno[2,3-b]pyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:68236-35-1 SDS

68236-35-1Relevant articles and documents

AMINOISOXAZOLINE COMPOUNDS AS AGONISTS OF ALPHA7-NICOTINIC ACETYLCHOLINE RECEPTORS

-

Paragraph 00381; 00382, (2017/05/19)

The present invention relates to novel aminoisoxazoline compounds, and pharmaceutical compositions of the same, that are suitable as agonists or partial agonists of α7-nAChR, and methods of preparing these compounds and compositions, and the use of these compounds and compositions in methods of maintaining, treating and/or improving cognitive function. In particular, methods of administering the compound or composition to a patient in need thereof, for example a patient with a cognitive deficiency and/or a desire to enhance cognitive function, that may derive a benefit therefrom.

Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds

-

, (2008/06/13)

The compounds of formula I herein exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, for treating a patient suffering from, or subject to, a physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.

SUBSTITUTED SULFONIC ACID N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLAMIDE COMPOUNDS

-

, (2008/06/13)

The compounds of formula I exhibit useful pharmacological activity and accordingly are incorporated into pharmaceutical compositions and used in the treatment of patients suffering from certain medical disorders. More specifically, they are inhibitors of the activity of Factor Xa. The present invention is directed to compounds of formula I, compositions containing compounds of formula I, and their use, which are for treating a patient suffering from, or subject to, physiological condition which can be ameliorated by the administration of an inhibitor of the activity of Factor Xa.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 68236-35-1